Dabur India Limited has informed the Exchange about Investor Presentation
DABUR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dabur reported muted FY25 results with consolidated revenue of INR 12,563 Cr, up just 1.3% YoY, while operating profit fell 3.5% to INR 2,316 Cr and net profit declined 4.1% to INR 1,768 Cr. Operating margin contracted by ~100 bps from 19.4% to 18.4% in FY25, with Q4 FY25 showing sharper weakness — revenue grew only 0.6% while operating profit fell 8.5% and PAT dropped 8.4%. The international business was a bright spot, posting 17.2% constant currency growth in FY25 (19.3% in Q4), contributing ~26% to overall sales. Domestic segments like Home & Personal Care and Healthcare saw declines, though Foods grew 14.2% and Badshah delivered 11% volume growth. The company announced a healthy total dividend of INR 8 per share (800%), with total payout of INR 1,417.86 Cr, and outlined a refreshed strategy focused on profitable growth, premiumization, portfolio rationalization, and strategic M&A in health & wellness.
Weak Q4 with margin pressure and a flat domestic FMCG performance may weigh on near-term sentiment, but the strong international growth, robust dividend yield, and clear strategic roadmap to revive profitability could provide some support. Shareholders should watch execution of the strategy refresh and margin trajectory in the coming quarters.